Jump to content
RemedySpot.com

TMC435 for Hepatitis C Phase 3 Studies Fully Enrolled, Company Says

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 11

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

TMC435 for Hepatitis C Phase 3 Studies Fully Enrolled,

Company SaysMedivir announced

last week that Phase 3 clinical trials of its

investigational hepatitis C virus (HCV) protease inhibitor,

TMC435 (initially developed by Tibotec/Janssen), are have

completed enrollment and participants have begun receiving

randomized treatment.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...